VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Discovering drug resistance mechanisms in multiple myeloma & identifying novel treatment targets

Yael Cohen, MD, Tel-Aviv Sourasky Medical center, Tel-Aviv, Israel, outlines the different mechanisms of drug resistance in multiple myeloma, highlighting the possibility of finding new treatment targets using single-cell RNA sequencing (scRNA-seq). This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter